Cleveland Clinic's 20th Annual ASH Review
H

2019 ASH Review of MDS: Clonal Hematopoiesis Increases Risk for Hematological Malignancies and Increases With Aging

By Cleveland Clinic's 20th Annual ASH Review FEATURING Hetty E. Carraway
By Cleveland Clinic's 20th Annual ASH Review FEATURING Hetty E. Carraway
22 views
April 14, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

07:44
Incyte

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Related Videos

Penn Medicine Abramson Cancer Center

2025 Breast Cancer Highlights from International Medical Meetings: 5…

Thu, Mar 6, 2025
Total Health

2025 West Oncology Conference

Sat, Feb 8, 2025
14:01

ESMO 2024 Summary: Highlights in Heme Malignancies

2024 ESMO Annual Meeting Insights Hub

M. Gomes da Silva

499 views
07:49

A Case of CMML With Recurrent Skin Involvement

XV Eurasian Hematology-Oncology Congress - EHOC 2024

E. Arslan Davulcu

15 views
06:46

ASH 2023 Insights: "Guadecitabine in Higher-Risk MDS and CMML Under …

Insights from 2023 ASH Annual Meeting

S. Urrutia

63 views
10:38

ASH 2023 Insights: "Venetoclax Improves Response Rates But Not Survi…

Insights from 2023 ASH Annual Meeting

D. Tremblay

37 views
11:20

SOHO 2021 Update on CMML Overview of the Most Recent Data

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

G. Montalban-Bravo

57 views
15:33

2020 SOHO Updates on Oral HMAs in MDS: Can FDA-Approved Decitabine/C…

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

G. Garcia-Manero

165 views
10:43

MD Anderson Immune Checkpoint Based Approaches in AML & MDS: Which C…

Naval Daver

148 views
21:24

2020 Update on Atypical CML, CMML & CNL: Is There Clinical Benefit t…

University of Miami's 2nd Biennial Miami Leukemia Symposium

J. Tyner

41 views
12:19

How to Calculate Risk in MDS Patients?

University of Miami's 2nd Biennial Miami Leukemia Symposium

M. Sekeres

93 views
22:02

TGF Beta Pathway Inhibition in MDS: Luspatercept Significantly Decre…

University of Miami's 2nd Biennial Miami Leukemia Symposium

A. Verma

115 views
18:24

In Transplant-Eligible Patients With Higher-Risk MDS, Hypomethylatin…

Moffitt Cancer Center's 16th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies

A. Mishra

189 views
14:59

In Transplant-Eligible Patients With Higher-Risk MDS, Hypomethylatin…

Moffitt Cancer Center's 16th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies

R. Komrokji

181 views
14:36

Frontline Therapies in MDS: Leveling Lower-risk MDS

University of Miami's 2nd Biennial Miami Leukemia Symposium

M. Sekeres

40 views
20:00

MDS/MPN Overlap Through Interactive Case Based Discussion: Overview …

Moffitt Cancer Center's 16th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies

A. Kuykendall

44 views
05:28

Frontline Therapies in MDS: Hampering Higher-risk MDS

University of Miami's 2nd Biennial Miami Leukemia Symposium

M. Sekeres

19 views
26:41

2019 ASH Review on MDS: Luspatercept Under FDA Review, Novel Oral HM…

Cleveland Clinic's 20th Annual ASH Review

H. Carraway

27 views
20:06

2020 Update on Splicing in MDS: How Can We Target Spliceosome-Mutant…

University of Miami's 2nd Biennial Miami Leukemia Symposium

T. Graubert

11 views
11:18

Relapse After Allo HSCT - Treatment Strategies and Overview of Relat…

Indy Hematology Review

R. Childs

130 views
19:25

MDS/MPN: Senectus Ipsa Est Morbus (Disease of Old Age)?

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

M. Deininger

78 views
06:53

Chronic Myelomonocytic Leukemia: Define, Diagnosis, Prognostications…

Indy Hematology Review

A. Tefferi

303 views
AUTOPLAY